e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Emergent BioSolutions Inc. Common Stock (NY:EBS)

8.025 +0.025 (+0.31%)

Streaming Delayed Price Updated: 1:57 PM EDT, Jun 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Earnings Outlook For Emergent BioSolutions ↗

July 29, 2022

Emergent BioSolutions (NYSE:EBS) is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement. Analysts estimate that Emergent...

Via Benzinga

Monkeypox Stocks SIGA, GOVX, BVNRY, CHMX, EBS Soar on Global Health Emergency ↗

July 25, 2022

Drugs and vaccines used against smallpox are seen as the first line of defense against the rising tide of monkeypox infections.

Via InvestorPlace

WWE, Infrastructure and Energy Alternatives And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

July 25, 2022

Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) shares rose 26% to $13.14 in pre-market trading. MasTec announced plans to acquire Infrastructure and Energy Alternatives for $14 per share...

Via Benzinga

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug ↗

July 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Merck Partner Joins Forces With Emergent Bio To Increase Access To Ebola Treatment ↗

July 08, 2022

Via Benzinga

Monkeypox Stocks BVNRY, EBS, CMRX, SIGA Heat Up on U.S. Vaccine Stockpile ↗

June 29, 2022

Pharmaceutical companies that make vaccines against monkeypox are getting attention as demand for treatments against the virus grow.

Via InvestorPlace

White House Outlines New Monkeypox Vaccine Strategy: What You Need To Know ↗

June 29, 2022

Via Benzinga

U.S. FDA Accepts Emergent's Anthrax Vaccine Candidate Filing For Review ↗

June 24, 2022

The U.S. Food and Drug Administration (FDA) has accepted to review Emergent BioSolutions’ (NYSE: EBS) Biologics License Application (BLA) for its new anthrax vaccine candidate AV7909. The regulatory...

Via Benzinga

7 Penny Stocks That Could Triple in 2022 ↗

June 22, 2022

Penny stocks are affordable and some with credible business models in all likelihood have the potential to generate superior returns.

Via InvestorPlace

7 No-Brainer Biotech Stocks to Add to Your Buy List ↗

June 09, 2022

With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile.

Via InvestorPlace

7 Monkeypox Stocks That May Take Off in Q2 ↗

June 09, 2022

SIGA Technologies (SIGA) may lead on the list of Monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race.

Via InvestorPlace

Morning Brief: Top Financial Stories Dominating on Tuesday, June 7 ↗

June 07, 2022

Reuters

Via Benzinga

J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement ↗

June 07, 2022

Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS).

Via Benzinga

Emergent Bio Says Johnson & Johnson Breached COVID-19 Vaccine Contract ↗

June 06, 2022

Emergent BioSolutions Inc (NYSE: EBS) said Johnson & Johnson (NYSE: JNJ) had breached an agreement by failing to buy the company's minimum quantity of COVID-19 vaccines.

Via Benzinga

Monkeypox Outbreak Puts Focus On These Two Biotechs ↗

May 27, 2022

Just when you thought it was safe to go outside, monkeypox pops up. Still, this might not be bad news for the market, as the world will turn once again to vaccine makers to find a solution.

Via Talk Markets

7 Monkeypox Stocks to Watch Right Now ↗

May 24, 2022

Wondering what are the best monkeypox stocks to watch? Here are the companies producing vaccines to help fight the spread of the virus.

Via InvestorPlace

Morning Brief: Top Financial Stories Dominating on Tuesday, May 24 ↗

May 24, 2022

CNBC

Via Benzinga

WHO Says Monkeypox Outbreak 'Unusual' But 'Containable' ↗

May 24, 2022

The World Health Organization (WHO) said that there had been 131 confirmed monkeypox cases and 106 further suspected cases,

Via Benzinga

Why Emergent Biosolutions Stock Is Rising Today ↗

May 23, 2022

Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher Monday amid increasing monkeypox concerns.

Via Benzinga

24 Stocks Moving in Monday's Pre-Market Session ↗

May 23, 2022

Gainers Genocea Biosciences, Inc. (NASDAQ: GNCA) shares rose 33.8% to $0.2795 in pre-market trading after declining around 5% on Friday.

Via Benzinga

6 Stocks To Watch Amid Monkeypox Outbreak ↗

May 20, 2022

A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts.

Via Benzinga

Stock Market Recap: This Week’s 5 Top Stories ↗

May 20, 2022

It's been a busy week for the stock market and we're going over all the latest news that investors need to know about with a recap!

Via InvestorPlace

Monkeypox Stocks: SIGA, EBS and TNXP Move Higher on Smallpox Vaccines, Treatments ↗

May 20, 2022

Monkeypox stocks SIGA, EBS and TNXP are all advancing as fears mount over monkeypox. The disease is related to smallpox.

Via InvestorPlace

71 Biggest Movers From Yesterday ↗

May 20, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

May 19, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for...

Via Benzinga

What Is Monkeypox Virus That Is Spreading in Europe, US ↗

May 19, 2022

Monkeypox was first discovered in the late 1950s after cropping up among monkeys kept for research. Like smallpox and chickenpox, it is characterized by flu-like symptoms and pus-filled blisters and...

Via Benzinga

Mid-Afternoon Market Update: Dow Jumps 300 Points; Crude Oil Rises Over 3% ↗

May 16, 2022

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 300 points on Monday.

Via Benzinga

73 Biggest Movers From Yesterday ↗

May 17, 2022

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.

Via Benzinga

Mid-Day Market Update: Dow Edges Higher; Data Storage Shares Surge ↗

May 16, 2022

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 20 points on Monday.

Via Benzinga

41 Stocks Moving In Monday's Mid-Day Session ↗

May 16, 2022

Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results.

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy